US EditionWeight loss jab Wegovy sales soar in UK as Mounjaro triples in price - Liverpool Echo
Wegovy sales in the UK rose by 2,660% after Mounjaro's 170% price increase, reflecting new users and existing patients switching treatments, health service access remains unchanged.
- Sales of Wegovy in the UK have surged after the maker of rival Mounjaro announced a price increase, with CheqUp reporting strong consumer interest in switching or starting Wegovy treatments.
- Eli Lilly last week announced Mounjaro's highest dose price will rise 170%, from £122 to £330 from September to align with European markets amid political pressure.
- On Wednesday the sales spike equated to a 27-fold increase in Wegovy sales, with the lowest dose costing 85 and highest dose 160 per month, amid over a million estimated users in the UK.
- The NHS will not pay the higher Mounjaro price, ensuring continued access for people with obesity and type 2 diabetes; Toby Nicol, chief executive of CheqUp, said last week demand has surpassed expectations with Wegovy set to become the UK's most popular weight-loss treatment.
- Mounjaro and Wegovy are both weekly injections with different active ingredients; CheqUp noted extraordinary growth across every Wegovy dose, showing both switches and new starters reshaping demand.
Insights by Ground AI
Does this summary seem wrong?
23 Articles
23 Articles
Warrington Guardian+19 Reposted by 19 other sources
Wegovy sales spike after maker of rival Mounjaro ramps up UK price
CheqUp said it had experienced a spike in interest from consumers wanting to switch or begin taking the medication.
·Warrington, United Kingdom
Read Full Article
Weight loss jab decision unfair on region -says MSP - DNG Online Limited
A DECISION not to prescribe the Mounjaro injection in this region for weight loss has been defended by NHS Dumfries and Galloway. The health board have been criticised by Galloway and West Dumfries MSP Finlay Carson for creating a ‘postcode lottery’ and denying access to the drug which has been approved by by the Scottish Medicines Consortium (SMC). However, health officials have pointed out the high cost of the drug, which is also used for diab…
Coverage Details
Total News Sources23
Leaning Left3Leaning Right0Center17Last UpdatedBias Distribution85% Center
Bias Distribution
- 85% of the sources are Center
85% Center
15%
C 85%
Factuality
To view factuality data please Upgrade to Premium
